Platform
Platform
-
LACOSTIM®- Overcome tumor microenvironment associated inhibitions
- Enhance T cell tumor killing and CAR-T cells persistence
- Orchestrate an adaptive immune response and enhance anti-tumor activity
-
Antibody- Fully human antibody discovery platform
- An industry-leading, high-quality library containing more than 100 billion antibodies
- Completed 23 TAA target-specific antibody screening
-
mRNA- One-day manufacturing
- Non-viral delivery system
- Cost-effective CAR-T production
-
Off-the-shelf- Optimized CRISPR/CAS9 system
- VETO like T cell
- NK and iPSC
